by admin | Sep 20, 2022 | News, Zantac Cancer, Consumer Products
Zantac belongs to a group of medications known as histamine-2 blockers. These drugs reduce acid production in the stomach for those diagnosed with gastroesophageal reflux disease (GERD), Zollinger Ellison syndrome, and other conditions causing heartburn and ulcers.... by michael | Apr 1, 2020 | Zantac Cancer
The FDA is asking all manufacturers remove prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately. The FDA also noted an ongoing investigation into the level of contaminate, NDMA in the medication. About NDMA... by michael | Apr 1, 2020 | Zantac Cancer
Zantac, the popular heartburn medication has recently been recalled due to increased cancer risk. However, medical professionals have been warning against the dangers for decades. GlaxoSmithKline (GSK), the manufacturer of Zantac even responded to these accusations,... by michael | Mar 27, 2020 | Zantac Cancer
Recently, Zantac has been recalled due to increased cancer risks. However, many consumers do not realize that the cancer-causing chemical found in Zantac (NDMA) can trigger dormant cancerous growth in a variety of organs. Many have no idea that their cancer could have... by michael | Jan 27, 2020 | Zantac Cancer
As more people discover that their heartburn medication caused their cancer. They have turned to firms like The Michael Brady Lynch Firm who are leaders in this litigation to help file their Zantac cancer lawsuits. For a free consultation, call today. About... by michael | Jan 23, 2020 | Zantac Cancer
The first Zantac lawsuit was filed after a cancer-causing substance was found in the heartburn drug during lab testing. Zantac and its generic form, ranitidine, both tested positive for the impurity. The FDA and drug manufacturers are investigating this problem. As...
Recent Comments